Resistant mutations and quasispecies complexity of hepatitis B virus during telbivudine treatment
Feifei Yin(Chinese Academy of Sciences), Zhìhóng Hú(East China University of Science and Technology), Ruikun Du(Shandong University of Traditional Chinese Medicine), Meifang Han(Tongji Hospital), Simon Rayner(Chinese Academy of Sciences), Huálín Wáng(Chinese Academy of Sciences), Qin Ning(Huazhong University of Science and Technology), Jinliang Liu(Chinese Academy of Sciences), Zeguang Wu(Peking University), Manli Wang(Chinese Academy of Sciences), Fang Wei(Zhengzhou University), Fēi Dèng(Hubei University of Medicine), Chunchen Wu(Xiamen University)
Cited by 12
Related Papers
Attenuated replication and pathogenicity of SARS-CoV-2 B.1.1.529 Omicron
|RePEc: Research Papers in Economics|0|647
Taxonomy of the order Bunyavirales: update 2019
|Archives of Virology|2019|398
Acute liver failure: mechanisms of immune-mediated liver injury
|Liver International|2010|280